Eric Guenin

589 total citations
57 papers, 418 citations indexed

About

Eric Guenin is a scholar working on Dermatology, Cell Biology and Epidemiology. According to data from OpenAlex, Eric Guenin has authored 57 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Dermatology, 19 papers in Cell Biology and 9 papers in Epidemiology. Recurrent topics in Eric Guenin's work include Acne and Rosacea Treatments and Effects (43 papers), Skin Protection and Aging (19 papers) and melanin and skin pigmentation (15 papers). Eric Guenin is often cited by papers focused on Acne and Rosacea Treatments and Effects (43 papers), Skin Protection and Aging (19 papers) and melanin and skin pigmentation (15 papers). Eric Guenin collaborates with scholars based in United States, Canada and Switzerland. Eric Guenin's co-authors include Linda Stein Gold, Radhakrishnan Pillai, Fran Cook-Bolden, Helmut H. Albrecht, Hilary Baldwin, Peter V. Dicpinigaitis, Valerie Callender, Leon Kircik, Emil Tanghetti and Varsha Bhatt and has published in prestigious journals such as Journal of Investigative Dermatology, Journal of the American Academy of Dermatology and The Journal of Clinical Pharmacology.

In The Last Decade

Eric Guenin

51 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Guenin United States	12	276	158	61	37	30	57	418
Jessica Sprague United States	5	210 0.8×	34 0.2×	32 0.5×	28 0.8×	11 0.4×	8	285
Anne Schmitt France	10	257 0.9×	43 0.3×	59 1.0×	39 1.1×	10 0.3×	15	460
H Pawin France	9	499 1.8×	96 0.6×	33 0.5×	18 0.5×	8 0.3×	15	570
Jean‐Paul Claudel France	8	248 0.9×	24 0.2×	115 1.9×	29 0.8×	34 1.1×	11	332
M Chivot France	16	790 2.9×	214 1.4×	66 1.1×	131 3.5×	21 0.7×	30	940
Michèle Sayag France	9	211 0.8×	17 0.1×	16 0.3×	49 1.3×	6 0.2×	22	326
Olimpia Dumitriu Buzia Romania	10	50 0.2×	23 0.1×	21 0.3×	26 0.7×	6 0.2×	26	266
Melissa D. Gover Canada	4	367 1.3×	267 1.7×	35 0.6×	21 0.6×	1 0.0×	6	455
A Zesch Germany	12	285 1.0×	27 0.2×	38 0.6×	52 1.4×	4 0.1×	48	521
Maodo Ndiaye Senegal	8	26 0.1×	37 0.2×	76 1.2×	17 0.5×	24 0.8×	45	332

Countries citing papers authored by Eric Guenin

Since Specialization

Citations

This map shows the geographic impact of Eric Guenin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Guenin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Guenin more than expected).

Fields of papers citing papers by Eric Guenin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Guenin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Guenin. The network helps show where Eric Guenin may publish in the future.

Co-authorship network of co-authors of Eric Guenin

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Guenin. A scholar is included among the top collaborators of Eric Guenin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Guenin. Eric Guenin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feldman, Steven R., Linda Stein Gold, Emil Tanghetti, Leon Kircik, & Eric Guenin. (2025). Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Association of Efficacy With Cutaneous Safety/Tolerability Events. SKIN The Journal of Cutaneous Medicine. 9(2). s556–s556. 1 indexed citations

Lipner, Shari R., Aditya K. Gupta, Warren S. Joseph, et al.. (2025). Efficacy and Safety of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Older Adults. SKIN The Journal of Cutaneous Medicine. 9(2). s567–s567.

Kircik, Leon, Julie Harper, Michael A. Gold, et al.. (2025). Safety and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Truncal Acne. Journal of Drugs in Dermatology. 24(8). 803–809.

Draelos, Zoé Kececioglu, Leon Kircik, Joshua Zeichner, et al.. (2024). The Right Formula for Acne: Importance of Vehicle Formulation in Tazarotene 0.045% Lotion Design, Application, Tolerability, and Efficacy. Dermatologic Therapy. 2024(1). 1 indexed citations

Harper, Julie, Leon Kircik, Michael A. Gold, et al.. (2024). Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel.. PubMed. 23(3). 125–131. 1 indexed citations

Gupta, Aditya K., Boni E. Elewski, Warren S. Joseph, et al.. (2024). Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agents. Mycoses. 67(1). e13683–e13683. 25 indexed citations

Cook-Bolden, Fran, Linda Stein Gold, Hilary Baldwin, et al.. (2023). Safety of Tazarotene 0.045% Lotion and Hyperpigmentation Improvements in Black Participants With Moderate-to-Severe Acne. SKIN The Journal of Cutaneous Medicine. 7(4). s221–s221. 1 indexed citations

Tanghetti, Emil, Joshua Zeichner, Michael H. Gold, et al.. (2022). Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin. Journal of Dermatological Treatment. 34(1). 2147391–2147391. 5 indexed citations

Callender, Valerie, Hilary Baldwin, Fran Cook-Bolden, et al.. (2021). Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice. American Journal of Clinical Dermatology. 23(1). 69–81. 43 indexed citations

10.

Baldwin, Hilary, Guy Webster, Linda Stein Gold, et al.. (2021). 50 Years of Topical Retinoids for Acne: Evolution of Treatment. American Journal of Clinical Dermatology. 22(3). 315–327. 42 indexed citations

11.

Gupta, Aditya K., M. Venkataraman, William Abramovits, & Eric Guenin. (2021). JUBLIA (Efinaconazole 10% Solution) in the Treatment of Pediatric Onychomycosis.. SKINmed Dermatology for the Clinician. 19(3). 206–210. 1 indexed citations

12.

Eichenfield, Lawrence F., Emil Tanghetti, & Eric Guenin. (2020). 603 Treatment of moderate-to-severe acne with once-daily tazarotene 0.045% lotion in pediatric patients: Pooled analysis of two phase 3 studies. Journal of Investigative Dermatology. 140(7). S82–S82. 1 indexed citations

13.

Tyring, Stephen K., Leon Kircik, David M. Pariser, et al.. (2020). The Effects of Once-Daily Tretinoin 0.05% Lotion on Quality of Life in Patients with Moderate-to-Severe Acne Vulgaris. American Journal of Clinical Dermatology. 21(6). 891–899. 1 indexed citations

14.

Eichenfield, Lawrence F., Boni E. Elewski, Jeremy Sugarman, et al.. (2020). Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients. Journal of Drugs in Dermatology. 19(9). 867–872. 9 indexed citations

15.

Eichenfield, Lawrence F., Boni E. Elewski, Jeremy Sugarman, et al.. (2020). Efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients: Open-label phase 4 study. Journal of the American Academy of Dermatology. 84(4). 1140–1142. 11 indexed citations

16.

Bhatia, Neal, William Philip Werschler, Fran Cook-Bolden, & Eric Guenin. (2020). Tolerability of Tretinoin Lotion 0.05% for Moderate to Severe Acne Vulgaris: A Post Hoc Analysis in a Black Population. Cutis. 106(1). 45–50;E1. 5 indexed citations

17.

Eichenfield, Lawrence F., Jeremy Sugarman, Eric Guenin, Susan Harris, & Varsha Bhatt. (2019). Novel tretinoin 0.05% lotion for the once‐daily treatment of moderate‐to‐severe acne vulgaris in a preadolescent population. Pediatric Dermatology. 36(2). 193–199. 12 indexed citations

18.

Tanghetti, Emil, Leon Kircik, Lawrence J. Green, et al.. (2019). A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris. PubMed. 18(6). 542–542. 20 indexed citations

19.

Cook-Bolden, Fran, Michael H. Gold, & Eric Guenin. (2019). Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males. Journal of Drugs in Dermatology. 19(1). 78–85. 5 indexed citations

20.

Guenin, Eric, et al.. (2014). Pharmacokinetic Profile of Dextromethorphan Hydrobromide in a Syrup Formulation in Children and Adolescents. Clinical Drug Investigation. 34(9). 609–616. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact